TinnoKart in Clinical Context
TinnoKart is Earkart's caroverine 20 mg capsule, developed for the management of tinnitus as part of the division's specialist-focused ENT portfolio. It is a prescription product, intended for use only under the direction of a Registered Medical Practitioner — typically within ENT-led care.
Tinnitus is the perception of sound — often described as ringing, buzzing or hissing — in the absence of an external source. It is a symptom rather than a single disease, and it can be associated with a wide range of underlying factors, from noise exposure and age-related hearing changes to ear canal, middle-ear or other medical conditions. Because the causes are so varied, careful evaluation by an ENT specialist is the essential first step in tinnitus care; treatment decisions follow from that assessment.
Earkart deliberately positions TinnoKart with restraint. Tinnitus management is individualised, responses differ between patients, and no responsible manufacturer should suggest a uniform outcome. TinnoKart is presented as one physician-directed option within a broader management plan that a specialist may design — which can also include hearing assessment, counselling and management of contributing conditions.
Tinnitus care is close to Earkart's identity as an ENT-focused organisation — the company also holds the globally patented OMNI remote audiometry technology, reflecting its wider commitment to hearing health. TinnoKart is manufactured to the division's WHO-GMP certified standards, and detailed product information is available to healthcare professionals and distribution partners on request.
